Tirzepatide access
Wellmedr vs SnagRx: Which One Offers Tirzepatide? (2026)
Wellmedr costs $1,068 a year against $1,188 for SnagRx. Full 2026 comparison of price, medication class and included support.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.2 and 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
SnagRx and Wellmedr both promise a fast route to GLP-1 treatment without an office visit. What they promise afterward is where they separate.
Molecule availability is the fork here: SnagRx covers both semaglutide and tirzepatide, while Wellmedr publishes semaglutide alone. That matters most to anyone who may want to switch rather than simply escalate.
Each program is read on its own published terms first, then against the other on the four things that decide satisfaction: price, predictability, formulary and access to a clinician. Gaps in a provider's disclosure are reported as gaps, because they are part of what you are buying.
The short answer
- Lowest 12-month cost
- SnagRx — $828 against $1,068 at Wellmedr, on each provider's own best published pricing.
- Most predictable bill
- Wellmedr — Price locked for the life of the plan, so titration does not change what you are charged.
- Tirzepatide access
- SnagRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Widest medication choice
- SnagRx — compounded semaglutide and compounded tirzepatide.
Side-by-side comparison
Scan the pricing rows first, then the medication row. Those two settle most of these decisions between them.
| Wellmedr | SnagRx | |
|---|---|---|
| Advertised price | Semaglutide from $89/mo on the 1-year plan | Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan |
| Rate after promotions | $89/mo | $99/mo |
| Pricing structure | Price locked for the life of the plan | Flat rate at every dose |
| Medication | Compounded semaglutide | Compounded semaglutide and compounded tirzepatide |
| Tirzepatide | Not published | $149/mo |
| Shipping | Free overnight shipping | Free next-day UPS or FedEx in temperature-controlled packaging |
| Payment options | Card only, no financing published | Card only, no financing published |
| Price transparency | Partly published | Published upfront |
| Support model | No coaching program stated | No coaching program stated |
| Patient reviews | 4,925 | 9,860 |
| eRxDoctor score | 9.2/10 | 7.5/10 |
The real cost: six months and twelve
Both providers lead with a number designed to get you through the intake. The figures underneath convert both offers into what you will have spent by month six and month twelve.
| Wellmedr | SnagRx | |
|---|---|---|
| First month | $89 | $99 |
| Months 2 onward | $89/mo | $99/mo |
| 6-month total | $534 | $594 |
| 12-month total | $1,068 | $1,188 |
| Best published plan | No multi-month discount published | 12-month semaglutide plan at $69/mo ($828 a year) — $828/yr |
Over a year that is a $240 difference, in SnagRx's favor. Whether it is the right call depends on whether Wellmedr gives you $20 a month of something you will use.
Semaglutide, tirzepatide, and having somewhere to go next
Semaglutide is a GLP-1 receptor agonist. Tirzepatide adds GIP activity, and in head-to-head trial data it has produced larger average weight reductions. That does not make it the right first choice for everyone — it is typically more expensive and the side-effect profile is its own conversation — but it is the usual next step when semaglutide underdelivers.
SnagRx publishes both, with tirzepatide at $149/mo. Wellmedr publishes compounded semaglutide, so switching molecules would mean switching provider, repeating an intake and losing whatever pricing you had locked in.
The question to ask yourself is not which molecule you want now, but how much friction a change would create later.
Wellmedr in detail
The pitch is locked-in pricing with no dose-based increases at one of the lowest published rates. GLP-1 Plans Starting at Just $89/Month
You start with same-day review; medication arrives via free overnight shipping. The price behaves as price locked for the life of the plan.
On the clinical side, same-day clinician review, prescribing compounded semaglutide.
Wellmedr pros
- Lifetime locked-in pricing
- No dose-based price increases
Wellmedr cons
Where it gives ground to SnagRx: the $89 rate is tied to a one-year commitment and the platform publishes little else.
Inside the SnagRx program
SnagRx offers compounded semaglutide from $69/month and tirzepatide from $119/month, with the rate locked flat at every dose, named US 503A pharmacies and next-day shipping. In this pairing, its distinguishing feature is the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly.
From signup to first shipment: 5-minute intake, clinician review typically within 5 hours and always within 24, then free next-day UPS or FedEx in temperature-controlled packaging. Billing follows a flat rate at every dose structure.
What continues after the first shipment: 1:1 nursing staff plus a secure patient portal for refills and dose changes. Formulary: compounded semaglutide and compounded tirzepatide.
SnagRx pros
- Full refund if the prescription is declined, plus a 6-month weight-loss guarantee (terms apply)
- Clinician review typically within 5 hours; next-day temperature-controlled shipping
- States LegitScript certification, which patients can verify independently
- Names its four US 503A partner pharmacies and its clinician network (OpenLoop Health)
SnagRx cons
- No coaching or nutrition programming of any kind
- Heavy urgency marketing, including a countdown timer on the pricing page
- The advertised $69 and $119 rates require the 12-month plan; month-to-month is $99 and $149
Read next to Wellmedr, the weak point: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
Who should choose Wellmedr, and who should choose SnagRx
Choose Wellmedr if:
- the monthly rate is the constraint — $89/mo against $99/mo
- you want the price you sign up at to survive titration
- the twelve-month total is what you are optimizing ($1,068 against $1,188)
- what it leads on is worth paying for in your case: locked-in pricing with no dose-based increases at one of the lowest published rates
Choose SnagRx if:
- you want tirzepatide available without changing provider later
- you want the price you sign up at to survive titration
- you are willing to commit for a term in exchange for a lower effective rate (12-month semaglutide plan at $69/mo ($828 a year))
- you want the full price in front of you before completing an intake
Where each program concedes something
On price. $89/mo against $99/mo. SnagRx is asking you to pay for the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly; decide whether that is a line item you will use.
On access. Wellmedr advertises same-day review and free overnight shipping; SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24 and free next-day UPS or FedEx in temperature-controlled packaging. Coverage differs too — not published against 48 states — which decides the question before price does if you are in a restricted state.
On predictability. Price locked for the life of the plan at Wellmedr, against flat rate at every dose at SnagRx. The more predictable structure is worth a premium to anyone who has been surprised by a telehealth invoice before.
On clinical contact. Wellmedr provides same-day clinician review. SnagRx provides 1:1 nursing staff plus a secure patient portal for refills and dose changes. Both are asynchronous-first services and neither replaces a physician who can examine you.
What the trials and the FDA say
Neither Wellmedr nor SnagRx manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
The NIH position is that weight-management medication works alongside changes in eating and activity, not instead of them, per NIH, NIDDK.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
Take the clinical questions to the prescribing clinician at whichever platform you choose; take the pricing questions to their support team before you pay.
Wellmedr vs SnagRx: common questions
Which is cheaper to start, Wellmedr or SnagRx?
Wellmedr, at $89 against $99. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which has more patient reviews, Wellmedr or SnagRx?
SnagRx, with 9,860 against 4,925. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do Wellmedr or SnagRx take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
How fast can I start with Wellmedr compared with SnagRx?
Wellmedr advertises same-day review, with free overnight shipping. SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24, with free next-day UPS or FedEx in temperature-controlled packaging. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Can I switch from Wellmedr to SnagRx later?
Nothing stops you. The friction is administrative rather than clinical: a new intake, a new prescriber, and a delivery gap if you time it badly. Move while you still have two weeks of medication in the fridge, and read the cancellation terms on any prepaid plan before you do.
Is Wellmedr or SnagRx better for a first GLP-1 prescription?
If this is your first GLP-1, the question is who answers when nausea arrives on day nine. Wellmedr publishes same-day clinician review, which is the more useful thing to buy at the start.
The verdict
Strictly on cost, SnagRx takes it — $828 to $1,068 over twelve months.
The case for Wellmedr is locked-in pricing with no dose-based increases at one of the lowest published rates. That is worth $20 a month to some patients and nothing at all to others — be honest about which you are.
The failure mode here is not picking the wrong platform; it is stopping treatment because the bill moved. Choose the one whose bill you can predict.
Keep comparing
- Wellmedr vs WellorithmPublished price vs quote-only
- Wellmedr vs Ro.coBrand-name vs compounded
- MedVi vs SnagRxBudget vs premium
- JoinFridays vs SnagRxBudget vs premium
- Novi vs IVIM HealthTirzepatide access
- Novi vs Mochi HealthTirzepatide access
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Wellmedr or SnagRx, and does not sell treatment. Read our ranking methodology.